Fresenius | FRE - Nettoeinkommen

Aktienkurs
46.82
Täglich Wechseln
0.21 0.45%
Monatlich
-8.41%
Jährlich
17.28%
Q1 Prognose
45.46




Nettoeinkommen Veränderung Datum
Akzo Nobel EUR 598M 792M 2025-12
Alcon AG USD 217M 20M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
BASF EUR 560M 388M 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Beiersdorf EUR 387M 165M 2025-12
DaVita Healthcare Partners USD 234.22M 83.88M 2025-12
Demant DKK 427M 690M 2025-12
E.ON EUR 816M 867M 2025-12
Essilor EUR 928M 459M 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 327M 52.2M 2025-12
Getinge SEK 662M 661M 2024-12
Givaudan CHF 294M 150M 2024-06
GlaxoSmithKline GBP 636M 1.38B 2025-12
GN Store Nord DKK 344M 271M 2025-12
GRIFOLS EUR 98.25M 28.72M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Lonza CHF 307M 22M 2024-12
Merck EUR 319M 583M 2025-12
Novartis USD 3.93B 96M 2025-09
Philips EUR 395M 211M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
RWE EUR 846M 183M 2025-09
Sanofi EUR -801M 3.6B 2025-12
Smith & Nephew USD 293M 79M 2025-12